Evidence map›Paper›PMID 22044255›Full record

ArticleACS nano2011

Antitumor activity of peptide amphiphile nanofiber-encapsulated camptothecin.

Stephen Soukasene, Daniel J Toft, Tyson J Moyer, Hsuming Lu, Hyung-Kun Lee, Stephany M Standley, Vincent L Cryns, Samuel I Stupp

Abstract read
In one paragraph

Article in ACS nano, 2011. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 67 papers.

0numbers the graph read from it
0cells of the map it votes in
67citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

67 citing papers in PubMed.

  1. Review
  2. Article
  3. Article
  4. Article
  5. Review
  6. Article
  7. Peptides as carriers of active ingredients: A review.Current research in food science · 2023
    Review
  8. Article
  9. Article
  10. Article
  11. BH3-mimetics: recent developments in cancer therapy.Journal of experimental & clinical cancer research : CR · 2021
    Review
  12. Review
  13. Article
  14. Review
  15. Review
  16. Review
  17. Article
  18. Design of materials with supramolecular polymers.Progress in polymer science · 2020
    Review
  19. Article
  20. Article

7 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Stephen SoukaseneInstitute for BioNanotechnology in Medicine, Northwestern University, Chicago, Illinois 60611, USA.
Daniel J Toft
Tyson J Moyer
Hsuming Lu
Hyung-Kun Lee
Stephany M Standley
Vincent L Cryns
Samuel I Stupp

Funding

Tumor Environment and Metastasis (TEAM) Research ProgramP30CA060553 · NCI · NORTHWESTERN UNIVERSITY AT CHICAGO · PI Daniela E Matei · 1993 to 2026
$153.9M
TiO2 nanocomposites for Targeted Treatment and Imaging of Prostate cancerU54CA119341 · NCI · NORTHWESTERN UNIVERSITY AT CHICAGO · PI WOLOSCHAK, GAYLE E. · 2005 to 2009
$19.9M
Theranostic Magnetic Nanostructures for the Molecular Imaging of CancerU54CA151880 · NCI · NORTHWESTERN UNIVERSITY AT CHICAGO · PI MIRKIN, CHAD A., ROSEN, STEVEN TERRY · 2010 to 2014
$11.5M
TRAINING IN METABOLISM, DIABETES AND ENDOCRINOLOGYT32DK007169 · NIDDK · NORTHWESTERN UNIVERSITY AT CHICAGO · PI Joseph Bass · 1988 to 2026
$6.6M
Tumor Targeted Nanobins for the Treatment of Metastatic Breast and Ovarian CancerU01CA151461 · NCI · NORTHWESTERN UNIVERSITY AT CHICAGO · PI O'HALLORAN, THOMAS V · 2010 to 2014
$2.2M
Dendritic Peptide Amphiphiles for Biomedical ApplicationsF32GM080021 · NIGMS · NORTHWESTERN UNIVERSITY AT CHICAGO · PI STANDLEY, STEPHANY · 2007 to 2009
$133k
NCI NIH HHS 1U54CA119341NCI NIH HHS P30 CA060553NCI NIH HHS U01 CA151461NCI NIH HHS U54 CA119341NCI NIH HHS U54 CA151880NIDDK NIH HHS T32 DK007169NIDDK NIH HHS T32DK0-07169NIGMS NIH HHS 5F32GM080021NIGMS NIH HHS F32 GM080021
6 · The paper itself

Abstract

Self-assembling peptide amphiphile (PA) nanofibers were used to encapsulate camptothecin (CPT), a naturally occurring hydrophobic chemotherapy agent, using a solvent evaporation technique. Encapsulation by PA nanofibers was found to improve the aqueous solubility of the CPT molecule by more than 50-fold. PAs self-assembled into nanofibers in the presence of CPT as demonstrated by transmission electron microscopy. Small-angle X-ray scattering results suggest a slight increase in diameter of the nanofiber to accommodate the hydrophobic cargo. In vitro studies using human breast cancer cells show an enhancement in antitumor activity of the CPT when encapsulated by the PA nanofibers. In addition, using a mouse orthotopic model of human breast cancer, treatment with PA nanofiber-encapsulated CPT inhibited tumor growth. These results highlight the potential of this model PA system to be adapted for delivery of hydrophobic therapies to treat a variety of diseases including cancer.

Indexed as

AnimalsAntineoplastic AgentsCamptothecinCell Line, TumorFemaleHumansHydrophobic and Hydrophilic InteractionsMiceNanocapsulesNanofibersPeptidesSolventsXenograft Model Antitumor AssaysAntineoplastic AgentsCamptothecinNanocapsulesPeptidesSolvents

Identifiers

PMID22044255
PMCPMC3229267

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.